Divis labs share price forecast zkrocta

Divis labs share price forecast

04.01.2021

Hedge71860

RSS stands for Really Simple Syndication. RSS feed is a XML file that provides summaries, including links to the full versions of the content.It is available through RSS feed reader or through some browsers. Profile Divis Laboratories MORE Divi's Laboratories Ltd. is a holding company, which engages in the manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. F&O Quote of Divis Lab Share Price, Future and Options Divis Lab Live BSE, NSE Charts, historical charts, F&O Quote, Stock quote of Divis Lab, Divis Lab News, Videos, Stock Market Reports Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates for in the United States, Asia, Europe, and internationally. Rewards Earnings are forecast to grow 22.36% per year The Quarterly Results page of Divi's Laboratories Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results. TOTAL INCOME 3.87 %

DIVISLAB Share Price - Divi s Laboratories Limited NSE INDIA Technical Analysis, Target, Important Levels, Latest News, Interactive Charts.

The Quarterly Results page of Divi's Laboratories Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results. TOTAL INCOME 3.87 % Divis Labs share price forecast – Stock finding resistance @ 1142. Technical chart of Divis labs (10-04-2018) indicates that stock finding strong trend line resistance at current levels, stock can see further price rise once it closes and holds above its recent top @ 1142. Divi's Laboratories Ltd. key Products/Revenue Segments include Active Pharma Ingredients which contributed Rs 4727.84 Crore to Sales Value (96.88 % of Total Sales), Export Incentives which contributed Rs 116.91 Crore to Sales Value (2.39 % of Total Sales), Scrap which contributed Rs 25.53 Crore to Sales Value (0.52 % of Total Sales) and Contract Fees which contributed Rs 9.38 Crore to Sales Value (0.19 % of Total Sales)for the year ending 31-Mar-2019.

Divi's Laboratories Ltd. analyst ratings, historical stock prices, earnings estimates & actuals. 532488.IN updated stock price target summary.

Divi's Laboratories Ltd. share price forecast Lower Nutraceutical sales impacted DIVIs 3QFY20 performance; however, we believe that the company is well

Divis Laboratories Ltd Live BSE Share Price today, Divislab latest news, 532488 announcements. Divislab financial results, Divislab shareholding, Divislab Based on our forecasts, a long-term increase is expected, the "Divis Laboratories Ltd" stock price prognosis for 2024-10-12 is 3979.800 INR. With a 5-year investment, the revenue is expected to be around +130.71%. Your current $100 investment may be up to $230.71 in 2024. Price (INR) 1,738.00 Today's Change 15.05 / 0.87% Shares traded 271.06k 1 Year change 34.21% Data delayed at least 15 minutes, as of Oct 18 2019 11:15 BST. You must be a registered user to save alerts. Please sign in or register. For the year ending June 2019 Divis Laboratories has declared an equity dividend of 800.00% amounting to Rs 16 per share. At the current share price of Rs 1633.30 this results in a dividend yield of 0.98%. The company has a good dividend track report and has consistently declared dividends for the last 5 years. DIVIS LABORATORIES Share Price Today: DIVIS LABORATORIES share price is up 0.6% to Rs 1,702.3 on the BSE. On the NSE, the DIVIS LABORATORIES share price is up 0.4% to Rs 1,700.6. The total volume of shares traded is 0.0 m. Overall, the broader S&P BSE HEALTHCARE Index is trading up by 0.3%. Divi's Laboratories Ltd. share price forecast The 13 reports from 7 analysts offering long term price targets for Divi's Laboratories Ltd. have an average target of 1748.00. The consensus estimate represents a downside of -8.62% from the last price of 1912.85. Divis Laboratories Live NSE/BSE Share Price: Get Divis Laboratories Stock Price details, News, Financial Results, Stock Charts, Returns, Research Reports and more By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.

I have been watching Divis laboratories(DL) for many months but refrained from After the USFDA observation, the stock has corrected more than it deserves. next year target 1126 which is the worst case scenario as per present situation.

Find the latest DIVIS LABORATORIES LTD. (DIVISLAB.BO) stock quote, history, news and other vital information to help you with your stock trading and investing. RSS stands for Really Simple Syndication. RSS feed is a XML file that provides summaries, including links to the full versions of the content.It is available through RSS feed reader or through some browsers. Profile Divis Laboratories MORE Divi's Laboratories Ltd. is a holding company, which engages in the manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients.